Group 1 - Ramsay Santé has successfully repriced its €1,025 million TLB4 from E+4.00% to E+3.25% and extended the maturity of its €425 million TLB3 by 2 years, merging both into a new single Term Loan B5 of €1,450 million maturing in August 2031 [1][6] - The transaction aims to optimize the company's cost of debt and extend debt maturities, enhancing financial flexibility [6] - The refinancing was arranged by BNP Paribas and Crédit Agricole CIB as Physical Bookrunners [6] Group 2 - Ramsay Santé is the leader in private hospitalization and primary care in Europe, employing 38,000 staff and collaborating with nearly 9,300 practitioners to treat over 12 million patients annually across 465 facilities in five countries [2] - The company offers a wide range of medical and surgical specialties, including Medicine, Surgery, Obstetrics, Follow-up Care, Rehabilitation, and Mental Health [2] - Ramsay Santé is committed to improving patient health through innovation and contributes to public health service missions wherever it operates [3] Group 3 - The company invests over €200 million annually to support the evolution and diversity of care pathways, enhancing access to care and committing to best-in-class healthcare [4] - Ramsay Santé engages in dialogue with stakeholders and strives to protect the planet to improve health outcomes [4]
RAMSAY SANTE : closing repricing 250217